Announcement under Regulation 30 (LODR) - Press Release
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Ltd reported consolidated Q1 FY26 revenue of Rs. 39.8 Crs, up 43.7% year-on-year (37.6% excluding Ayurvedagram Bali), driven by India Digital (44% growth), US Wellness Centers (90% growth), and Ayurvedagram Bangalore (20% growth). The company posted its first adjusted EBITDA profit of Rs. 6.4 Crs (excluding ESOP provisions), a swing of Rs. 5.4 Crs from the previous year, with reported EBITDA at Rs. 5.3 Crs and PAT at Rs. 2.03 Crs (up Rs. 1.57 Crs YoY). Results include a one-time Rs. 8.04 Crs gain from sale of land booked under other income. Core operating revenue growth (excluding one-time base effects) was 17%. Management has set a target to double the topline growth rate to 50% in FY26 and plans to raise funds in the near term to invest in marketing, technology, and international expansion.
This is a positive operating update showing a clear turnaround in profitability with first adjusted EBITDA profit and strong top-line growth across priority segments. The planned fundraise to support a 50% growth target could lead to dilution, which shareholders should watch for.